The Company has accumulated a growing body of evidence that highlights a link between alterations in the immune and inflammatory systems and the development of chronic human disease. The Company is establishing itself as a leader in the field of inflammatory and immune genetic DNA and RNA biomarkers that play a causative role in debilitating conditions, such as atherosclerosis/heart disease, diabetes, arthritis, inflammatory bowel disease, post-traumatic stress disorders (PTSD) and cancer.A proprietary state-of-the art data mining bioinformatics program, called ‘cluster analysis’ will be used to measure disease development susceptibility with potential for earlier diagnosis and intervention. The company is developing a healthcare program based on its proprietary genetic panels that will allow people to be their own healthcare advocate and take an active role in their health status as well as longevity.

Grace Health Technology, offers an enterprise solution ( Chain Link) for the Laboratory environment. Chain Link focuses on the interaction and interchange between the internal and external sales channel with the operations of the laboratory.Chain Link captures customer acquisition, customer demographics including insurance status, shipping and receiving information, inventory management as well as completed physician signed requisition orders. All of the captured and input data is maintained in a HIPPA compliant ecosystem.

Host of The Business Architect Show

Provides financial restructuring and interim management.

Orthopedic Medical Device Holding Company

EDM is quite simply early detection medicine. At Pulse4Pulse, we believe in screening patients from a preventative standpoint so that we are better able to treat proactively (preventing disease and healthcare complications) rather than treating reactively (treating them after diagnosis).